Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

The oncologist

Showing results (1-10 of 6,662) with videos related to

Pageof 667
Sort By:
The Oncologist|August 5, 2003
Behavioral risk factors in breast cancer: can risk be modified?Anne McTiernan
The Oncologist|August 5, 2003
Docetaxel-based combined-modality chemoradiotherapy for locally advanced non-small cell lung cancerGiorgio V Scagliotti, Andrew T Turrisi
The Oncologist|June 14, 2022
Improving Adherence to Adjuvant Endocrine Therapy in Sub-Saharan Africa: Challenges and Innovative Nurse-Driven SolutionsTemidayo A Fadelu, Lori Buswell, Benjamin O Anderson
The Oncologist|June 15, 2022
Ovarian Function Suppression: A Deeper Consideration of the Role in Early Breast Cancer and its Potential Impact on Patient Outcomes: A Consensus Statement from an International Expert PanelBolivar Arboleda, Rupert Bartsch, Evandro de Azambuja, et al.
The Oncologist|January 29, 2011
Report of a phase II study of clofarabine and cytarabine in de novo and relapsed and refractory AML patients and in selected elderly patients at high risk for anthracycline toxicityEdward Agura, Barry Cooper, Houston Holmes, et al.
The Oncologist|February 3, 2011
Measuring the symptom burden of lung cancer: the validity and utility of the lung cancer module of the M. D. Anderson Symptom InventoryTito R Mendoza, Xin Shelley Wang, Charles Lu, et al.
The Oncologist|October 9, 2010
Effects of mannose-binding lectin polymorphisms on irinotecan-induced febrile neutropeniaJessica M van der Bol, Floris A de Jong, Ron H van Schaik, et al.
The Oncologist|October 9, 2010
Obesity and the risk for a hematological malignancy: leukemia, lymphoma, or myelomaMarshall A Lichtman
The Oncologist|October 9, 2010
Is increasing physical activity necessary to diminish fatigue during cancer treatment? Comparing cognitive behavior therapy and a brief nursing intervention with usual care in a multicenter randomized controlled trialMartine M Goedendorp, Marlies E W J Peters, Marieke F M Gielissen, et al.
The Oncologist|October 9, 2010
Endometrial carcinoma: a review of chemotherapy, drug resistance, and the search for new agentsKatherine M Moxley, D Scott McMeekin
Pageof 667

Showing results (1-10 of 6,662) with videos related to

Sort By:
Pageof 667
The Oncologist|August 5, 2003
Behavioral risk factors in breast cancer: can risk be modified?Anne McTiernan
The Oncologist|August 5, 2003
Docetaxel-based combined-modality chemoradiotherapy for locally advanced non-small cell lung cancerGiorgio V Scagliotti, Andrew T Turrisi
The Oncologist|June 14, 2022
Improving Adherence to Adjuvant Endocrine Therapy in Sub-Saharan Africa: Challenges and Innovative Nurse-Driven SolutionsTemidayo A Fadelu, Lori Buswell, Benjamin O Anderson
The Oncologist|June 15, 2022
Ovarian Function Suppression: A Deeper Consideration of the Role in Early Breast Cancer and its Potential Impact on Patient Outcomes: A Consensus Statement from an International Expert PanelBolivar Arboleda, Rupert Bartsch, Evandro de Azambuja, et al.
The Oncologist|January 29, 2011
Report of a phase II study of clofarabine and cytarabine in de novo and relapsed and refractory AML patients and in selected elderly patients at high risk for anthracycline toxicityEdward Agura, Barry Cooper, Houston Holmes, et al.
The Oncologist|February 3, 2011
Measuring the symptom burden of lung cancer: the validity and utility of the lung cancer module of the M. D. Anderson Symptom InventoryTito R Mendoza, Xin Shelley Wang, Charles Lu, et al.
The Oncologist|October 9, 2010
Effects of mannose-binding lectin polymorphisms on irinotecan-induced febrile neutropeniaJessica M van der Bol, Floris A de Jong, Ron H van Schaik, et al.
The Oncologist|October 9, 2010
Obesity and the risk for a hematological malignancy: leukemia, lymphoma, or myelomaMarshall A Lichtman
The Oncologist|October 9, 2010
Is increasing physical activity necessary to diminish fatigue during cancer treatment? Comparing cognitive behavior therapy and a brief nursing intervention with usual care in a multicenter randomized controlled trialMartine M Goedendorp, Marlies E W J Peters, Marieke F M Gielissen, et al.
The Oncologist|October 9, 2010
Endometrial carcinoma: a review of chemotherapy, drug resistance, and the search for new agentsKatherine M Moxley, D Scott McMeekin
Pageof 667